Oncology News

Oncology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Yoshitaka Nishio, et al. - To investigate the usefulness of the overexpression of the human epidermal growth factor receptor (HER-2) oncoprotein in patients with bone metastatic prostate cancer as a marker for the time to recurrence and outcome after endocrine therapy...Conclusions: We consider that HER-2 overexpression, as measured by immunohistochemistry, may be useful as a marker of an unfavorable prognosis by predicting the interval until relapse and outcome after endocrine therapy in patients with bone metastatic prostate cancer

Today in Bone/Cartilage...keeping you current

Prostate cancer cells modulate osteoblast mineralisation and osteoclast differentiation through Id-1
British Journal of Cancer, 12/17/09

Epidermal growth factor signalling and bone metastasis
British Journal of Cancer, 12/17/09

Mechanisms of breast cancer bone metastasis
Cancer Letters, 12/17/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address